Medical News

RSS

LGM Pharma Reports Strong Revenues in First Year of CDMO Operations Along With Continued Growth in Its API Sourcing Business

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its long-established Active Pharmaceutical Ingredient (API) division and its new contract development and manufacturing (CDMO) division.

From LGM Pharma 16 Mar 2023

Study offers valuable insights about how young people understand chronic pain

Whether it’s headaches, abdominal pain, or unrelenting joint soreness, up to a third of young people in Australia experience chronic pain.

16 Mar 2023

Heart Foundation urges Australians with high cholesterol not to reject life-saving statins

The Heart Foundation is asking Australians with high cholesterol not to refuse to take life-saving statin medication after a new international study found that 1 in 5 people refuse their prescribed statins.

16 Mar 2023

Bormioli Pharma announces robust growth in its North American business in 2022

Bormioli Pharma, a global leader partnering with customers to provide comprehensive packaging solutions for injectable drugs, today announced robust growth in its North American business in 2022, with sales increasing more than 40% year-over-year.

16 Mar 2023

Diagnosis and treatment of food allergies using a molecular approach

Researchers discuss molecular methods for food allergy assessments, including diagnostic and prognostic markers, as well as existing therapies.

15 Mar 2023

Customized insole with integrated sensors can measure sole pressure directly in the shoe

Researchers at ETH Zurich, Empa and EPFL are developing a 3D-printed insole with integrated sensors that allows the pressure of the sole to be measured in the shoe and thus during any activity.

15 Mar 2023

The role of the fungal mycobiome in women's health

Researchers discuss the association between human mycobiota and female health.

15 Mar 2023

Artificial pancreas technology improves blood glucose control in young children with type 1 diabetes

Artificial pancreas technology improved blood glucose control in young children between ages 2 and 5 with type 1 diabetes, according to the results of the Pediatric Artificial Pancreas (PEDAP) Trial, a 13-week randomized controlled trial conducted at three pediatric diabetes centers across the United States.

15 Mar 2023

Combining AI and neuroscience to detect and predict neurological disorders

Researchers review the relationship between artificial intelligence and neuroscience.

15 Mar 2023

The relationship between intestinal microbiome dysbiosis and atherosclerosis

Researchers investigate the impact of intestinal microbiota dysbiosis on atherosclerotic cardiovascular disease incidence.

15 Mar 2023

An automated bioinformatics pipeline to monitor HIV data in real-time

Researchers discuss an automated bioinformatics pipeline to prospectively and routinely analyze HIV-1 sequence data

15 Mar 2023

Using probiotics to treat depression

Researchers discuss whether probiotics could be used as supplementary or primary therapy to manage major depressive disorder.

15 Mar 2023

Simple interventions to reduce consumption of junk food

In the current study, an international team of researchers conducted a feasibility randomized controlled trial to assess the effectiveness of an intervention associated with self-control to reduce consumption of indulgences over eight weeks.

15 Mar 2023

How does soy consumption affect the risk of type 2 diabetes and cardiovascular diseases?

A higher intake of plant protein could effectively improve metabolic health and lower CVD mortality. Recently, scientists in China reviewed existing literature and conducted a meta-analysis to understand the association between increased soy consumption and the risk of T2D and CVDs. This review is available in the journal Nutrients.

15 Mar 2023

Dementia risk is reduced by a Mediterranean diet

A new study in the journal BMC Medicine aimed to analyze the association between dementia incidence and MedDiet adherence as well as assess the interaction between genetic risk and diet for dementia.

15 Mar 2023

Efficacy of a single dose of MVA-BN smallpox vaccine against Mpox

A recent The Lancet Infectious Disease study focussed on estimating the effectiveness of a single dose of MVA-BN against Mpox in England. This observational study was conducted following the large-scale vaccination program that immunized the GBMSM group with the MVA-BN vaccine.

15 Mar 2023